Empagliflozin vs Lorazepam
Empagliflozin vs Lorazepam: Overview
This comparison examines the pharmacological differences between Empagliflozin and Lorazepam.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Lorazepam β 10-20 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Lorazepam β C15H10Cl2N2O2.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Lorazepam β 321.1580 g/mol.
Type: Empagliflozin β Small molecule; Lorazepam β Small molecule.